News
IRMD
43.42
-0.62%
-0.27
Weekly Report: what happened at IRMD last week (0429-0503)?
Weekly Report · 2d ago
IRADIMED CORPORATION - Quarterly Report on Form 10-Q for the Quarterly Period Ended March 31, 2024
Press release · 5d ago
IRMD Stock Earnings: iRadimed Beats EPS, Beats Revenue for Q1 2024
IRadimed reported earnings per share of 36 cents for the first quarter of 2024. The company reported revenue of $17.60 million. This was 2.73% better than the analyst estimate for the same period. I radimed also reported results for the fourth quarter of 2015.
Investorplace · 6d ago
IRadimed Corp reports results for the quarter ended in March - Earnings Summary
IRadimed Corp reports quarterly adjusted earnings of 36 cents per share for the quarter ended in March. Revenue rose 13.7% to $17.60 million from the same quarter last year. The company reported quarterly income of $4.14 million. Shares have fallen by 4.5% this quarter.
Reuters · 6d ago
iRadimed declares $0.15 dividend
Seeking Alpha · 6d ago
*IRadimed Sees 2Q Rev $17.6M-$17.8M >IRMD
Dow Jones · 6d ago
*IRadimed Sees FY24 Rev $72.0M-$74.0M >IRMD
Dow Jones · 6d ago
*IRadimed Sees FY24 EPS $1.37-EPS $1.47 >IRMD
Dow Jones · 6d ago
BRIEF-IRadimed Q1 EPS USD 0.32
Reuters · 6d ago
IRADIMED CORP: FOR FULL YEAR EXPECTS NON-GAAP DILUTED EARNINGS PER SHARE OF $1.52 TO $1.62
Reuters · 6d ago
IRADIMED CORP: FOR FULL YEAR OF 2024, COMPANY EXPECTS TO REPORT REVENUE OF $72.0 MLN TO $74.0 MLN
Reuters · 6d ago
Press Release: IRADIMED CORPORATION Announces -3-
Three months ended March 31, 2016, The company reported net income of $3.2 billion. Diluted earnings per share was $0.27 for the quarter. The company has a net loss of $1.1 billion for the first three months of the year. The Company has a total of $12.7 billion in shareholders' equity.
Dow Jones · 6d ago
*IRadimed 1Q Net $4.14M >IRMD
Dow Jones · 6d ago
Press Release: IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
IRADIMED CORPORATION reports record revenue of $17.6 million for the first quarter of 2024. The Company's Board of Directors declares a regular quarterly cash dividend of $0.15 per common share. The company is a leader in the development of innovative magnetic resonance imaging medical devices.
Dow Jones · 6d ago
*IRadimed 1Q Rev $17.6M >IRMD
Dow Jones · 6d ago
*iRadimed 1Q EPS 32c >IRMD
Dow Jones · 6d ago
*iRadimed 1Q Adj EPS 36c >IRMD
Dow Jones · 6d ago
IRadimed: Q1 Earnings Snapshot
IRadimed Corp. Reports net income of $4.1 million in its first quarter. The maker of IV devices that can be used in MRI machines posted revenue of $17.6 million in the period. Winter Springs, Florida-based company expects full-year earnings of $1.62 per share.
Barchart · 6d ago
Notable earnings before Thursday's open
Major earnings expected before the bell on Thursday include: ConocoPhillips (COP) and Shell (SHEL) Other earnings slated for release before Thursday's open include: Iron Mountain, Moderna, Organon and Shell. Notable earnings before the close of trading on Wednesday include: Exxon Mobil (XOM) and Chevron.
Seeking Alpha · 05/01 15:22
More
Webull provides a variety of real-time IRMD stock news. You can receive the latest news about Iradimed Corp through multiple platforms. This information may help you make smarter investment decisions.
About IRMD
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gausses.